The Influence of Dopamine Agonist Cabergoline on Oocyte Maturation in Women Undergoing Assisted Reproduction.

Trial Profile

The Influence of Dopamine Agonist Cabergoline on Oocyte Maturation in Women Undergoing Assisted Reproduction.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Cabergoline (Primary)
  • Indications Ovarian hyperstimulation syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Jul 2011 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
    • 20 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Apr 2011 Status changed from discontinued to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top